Sherilyn W. Driscoll

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study

Craig M. McDonald, Erik Henricson, Richard T. Abresch et al. · The Lancet · 2017 · 446 citations

Long-term Effects, Duchenne Muscular Dystrophy, Degenerative Disease +4

Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy

Luca Bello, Kevin M. Flanigan, Robert B. Weiss et al. · The American Journal of Human Genetics · 2016 · 72 citations · Full text

Neurodegenerative Diseases, Exon Variants, Signal Transduction +11

Outcomes in Adolescents with Postural Orthostatic Tachycardia Syndrome Treated with Midodrine and β‐Blockers

CINDY C. LAI, Philip R. Fischer, Chad K. Brands et al. · Pacing and Clinical Electrophysiology · 2009 · 68 citations

Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy

Marshall W. Hogarth, Peter J. Houweling, Kristen C. Thomas et al. · Nature Communications · 2017 · 65 citations · Full text

Interdisciplinary aerodigestive care model improves risk, cost, and efficiency

R. Paul Boesch, Karthik Balakrishnan, Rayna Grothe et al. · International Journal of Pediatric Otorhinolaryngology · 2018 · 34 citations

Sustainable Healthcare, Primary Care, Health Policy +5